Judge OKs Glaxo's $65M Settlement Of Antitrust Suit Over Paxil Patent Gaming

Law360, New York (April 27, 2005, 12:00 AM EDT) -- A federal judge has approved SmithKline Beecham's $65 million settlement of a class-action antitrust suit brought by consumers who accused the U.K. drug maker of filing "sham" patent lawsuits to delay generic competition for antidepressant Paxil.

U.S. District Judge John R. Padova approved the settlement and awarded $19 million in attorney fees to a team of plaintiffs lawyers, led by attorneys Ellen Meriwether of Miller Faucher & Cafferty in Philadelphia, Dianne M. Nast of Roda Nast in Lancaster, Pa., and Kenneth A. Wexler of The Wexler...
To view the full article, register now.